We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Device Simplifies Identification of Leishmania Hosts

By LabMedica International staff writers
Posted on 22 May 2017
Print article
Image: An illustration of one of two minimally invasive microbiopsy devices designed to simultaneously sample a person’s blood and skin in a way that mimics the mode of biting by which the sandflies acquire meals (Photo courtesy of the International Journal for Parasitology).
Image: An illustration of one of two minimally invasive microbiopsy devices designed to simultaneously sample a person’s blood and skin in a way that mimics the mode of biting by which the sandflies acquire meals (Photo courtesy of the International Journal for Parasitology).
Researchers have developed a novel device for obtaining essentially painless, minimally invasive microbiopsies (MBs) that mimic sand fly bites and meals, providing a convenient sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani in endemic areas.

Leishmania donovani species, parasites that cause visceral leishmaniasis (VL), are transmitted to humans by phlebotomine sandflies infected from a blood (+skin) meal taken upon biting an infected reservoir host animal – mainly humans (India and East Africa) or dogs (Latin America, Europe, Middle East, and North Africa). The majority of infected individuals remains asymptomatic, but serve as parasite reservoirs for transmission of the disease via sandflies. The gold standard for assessing infectiousness of human hosts to biting vector insects is xenodiagnosis – scoring infection rates among insectary-reared insects that had fed on humans suspected of being infected. However, when it comes to sandflies and leishmaniasis, xenodiagnosis is an intricate operation burdened by logistical hurdles and ethical concerns that prevent its effective application for population screening.

An international research team from Australia, Ethiopia, Israel, and USA, led by Alon Warburg, professor at Hebrew University Hadassah Medical School, has developed and tested minimally invasive microbiopsy (MB) devices designed to penetrate the skin to a depth of ∼200µm and absorb blood as well as skin cell lysates, mimicking the “pool-feeding” mode by which the sandflies acquire blood meals.

Using the devices, MBs taken from 137 of 262 volunteers in endemic VL foci in Ethiopia detected Leishmania parasites that could potentially be imbibed by sandflies upon feeding. Although the volume of MB samples was 10-fold smaller than finger-prick blood samples, Leishmania DNA detection rates from MBs were significantly higher, implying that skin, more often than blood, was the main source of parasites.

Volunteers with histories of VL were almost as likely as healthy volunteers to test positive by MBs, suggesting the importance of asymptomatic people as reservoir hosts. These MB devices could enable to reliably and efficiently assess both L. donovani infection rates among large numbers of asymptomatic carriers and their infectiousness to blood-feeding sandflies.

The study, by Kirstein OD et al, was published April 26, 2017, in the International Journal for Parasitology.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more